ESTROGENIC AND ANTIESTROGENIC ACTIVITIES OF COMMERCIAL DIETARY SUPPLEMENTS CONTAINING HERBAL INGREDIENTS AND ISOFLAVONES
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2016, Vol 8, Issue 11
Abstract
Objective: This study aimed to assess the estrogenic and antiestrogenic activities of five dietary supplements, commercially available for treatment of menopausal symptoms, before and after gastrointestinal digestion by employing a yeast steroid-regulated transcription system.Methods: Supplements (S) were extracted with either 80% methanol or water. Water extracts were subjected to simulated gastrointestinal (GI) digestion. Estrogenic and antiestrogenic activities were assessed by a steroid-regulated transcription system in Saccharomyces cerevisiae expressing the human estrogen receptor alpha.Results: The highest estrogenic activities were detected in both S1 methanol (2342.5±20.83 MU) and water (1225.6±20.6 MU) extracts (400 estradiol equivalents). Extracts showed antiestrogenic properties by reducing the transcriptional activity induced by estradiol in transgenic yeast. The highest antiestrogenic activity was detected in S2 methanol extract and S3 water extract, which inhibited estradiol activity by 76% and 64%, respectively. After GI digestion, S1, S2 and S3 extracts showed significantly higher estrogenic and antiestrogenic activities as ‘serum-available’ than ‘colon-available’ samples and S4 and S5 extracts showed significantly higher activities as ‘colon-available‘ than ‘serum-available‘ samples.Conclusion: All dietary supplements revealed estrogenic and antiestrogenic activities. The GI digestion demonstrated the availability of phytoestrogens for absorption in the blood stream. Supplements containing soy isoflavones and alfalfa ingredients had the highest estrogenic activities and could be more effective than supplements with complex plant formulation in alleviating menopausal symptoms and treating osteoporosis. The transgenic yeast assays proved to be a powerful tool for assessing the in vitro estrogenic and antiestrogenic activities of dietary supplements.Â
Authors and Affiliations
Paramita Basu, Sharon Sunny, Camelia Maier
MIPOMERSEN: A NOVEL THERAPEUTIC DRUG FOR THE TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA, HYPERLIPIDAEMIA, AND HYPERCHOLESTEROLEMIA
Familial Hypercholesterolemia (FH) is one of the most common autosomal dominant disorders which exist in either heterozygous form or a homozygous form. These two forms are prevalent in1 in500 and1 ina million population...
STUDY ON AVAILABILITY AND AFFORDABILITY OF ANTI HYPERTENSIVE MEDICINES IN THE STATE OF KERALA
Objective: Since the 1970s, one of the smallest Indian States, Kerala, has been internationally applauded for its excellent performance in its health indicators. Even if mortality is low, the morbidity (those suffering f...
DISCRIMINANT ANALYSIS OF SHODHANA (PROCESSING) ON BALIOSPERMUM MONTANUM MUELL (DANTI) ROOT SAMPLES BASED ON NEAR INFRARED SPECTROSCOPY AND MULTIVARIATE CHEMOMETRIC TECHNIQUE
Objective: To establish a noticeable and a justifiable identification system to assess the impact of shodhana (processing) on various levels of Baliospermum montanum (Danti) root samples obtained through shodhana (proces...
DETERMINATION OF ETILEFRINE HYDROCHLORIDE, FENOTEROL HYDROBROMIDE, SALBUTAMOL SULPHATE AND ESTRADIOL VALERATE USING SURFACE PLASMON RESONANCE BAND OF SILVER NANOPARTICLES
Objective: The aim of this work was to evaluate a simple, sensitive, effective and validated procedure for the determination of etilefrine hydrochloride, fenoterol hydrobromide, salbutamol sulphate and estradiol valerate...
FOOD–DRUG INTERACTION AND THEIR CLINICAL IMPLICATIONS: SELECTED INVESTIGATIONS
Food-drug interactions occur as a result of pharmacokinetic or pharmacodynamics mechanisms. Pharmacokinetic mechanisms include what the body does to a drug while Pharmacodynamics mechanisms involve what drugs do to the b...